Annemarie Stroustrup, MD Email Annemarie Stroustrup
- ASSOCIATE PROFESSOR | Pediatrics
- ASSOCIATE PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- ASSOCIATE PROFESSOR | Environmental Medicine & Public Health
- Newborn Medicine
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Hospital 212-241-6186212-241-6186
Dr. Annemarie Stroustrup is an Associate Professor with joint appointments to the Department of Pediatrics, Department of Environmental Medicine and Public Health, and Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. She is also the System Chief of Newborn Medicine at Mount Sinai Hospital and Director of Newborn Services for the Mount Sinai Health System as well as the Program Director for Mount Sinai’s Neonatal-Perinatal Medicine Fellowship.
In addition to attending in the NICU at Mount Sinai, Dr. Stroustrup heads a research program exploring the impact of hospital-based environmental exposures on multi-system long-term outcomes related to prematurity. Her multidisciplinary research interests span the fields of children’s environmental health, perinatal epidemiology, neonatology, and neurodevelopment.
- Congenital Disease
- Mechanical Ventilation
- Neonatal Intensive Care
- Neonatal Resuscitation
- Perinatal Neurologic Injury
- Therapeutic Hypothermia
MD, Harvard Medical School
MPH, Mount Sinai School of Medicine
Mount Sinai Hospital
Mount Sinai Hospital
Society for Pediatric Research Young Investigator Coaching Program Award
The Dr. Harold and Golden Lamport Clinical Research Award
The Kurt Hirschhorn Pediatric Resident Award for Academic Excellence Intellectual Curiosity
NIH Young Investigator Award for the 2008 Perinatal Research Society meeting
The Pasteur Award for clinical research, Harvard Medical School
Radiological Society of North America Magna Cum Laude Award for Excellence in Education
Dr. Stroustrup’s research interests bridge the disciplines of perinatal epidemiology, neonatology, and environmental health. Specifically, she works to better understand modifiable causes of adverse outcomes in neonates born preterm, low birth weight, or otherwise ill. Her current research focuses on elucidating potential environmental contributors to poor neurodevelopmental outcomes in NICU graduates. He research group’s website is located at http://labs.icahn.mssm.edu/stroustruplab.
Current research support:
UG3 OD023320 09/21/16 – 08/31/18
Developmental Impact of NICU Exposure (DINE)
Description: This contract is part of the NIH Environmental Influences on Child Health Outcomes (ECHO) Pediatric Cohorts program. The DINE cohort brings approximately 1,000 preterm infants born at 15 sites across the United States to ECHO, with the aim of evaluating the impact of NICU-based chemical andnon-chemical exposures on multi-system long-term outcomes to age 10.
Role: Co-I; site PI
NIH/ NIEHS 1K23ES022268-01 9/3/2013 – 5/31/2018
Chemical Exposures and Infant Outcomes in the Neonatal Intensive Care Unit
Description: In this project we aim to understand the impact of chemical and non-chemical (social, emotional) exposures in the hospital environment on long-term neurodevelopmental outcomes of preterm infants. This work could allow modification of the NICU experience to optimize outcomes for hundreds of thousands of children born preterm each year.
Completed research support:
Passport Foundation 12/1/2011 – 12/30/2013
Environmental chemical exposure in the neonatal intensive care unit
Description: In this project we are both assessing very low birth weight infants hospitalized in the neonatal intensive care unit for exposure to industrial chemicals and validating an exposure checklist tool.
Mount Sinai Children’s Environmental Health Center 7/1/2011-6/30/2013
Hospital-based phthalate exposure in very low birth weight neonates
Description: In this project we are investigating the relationship between phthalate and BPA exposure in the neonatal intensive care unit among very low birth weight infants and clinical outcomes including neurodevelopmental progress, somatic growth, and thyroid function.
NIH KL2RR029885 7/1/2010 – 6/30/2012
Identification of early predictors of fetomaternal hemorrhage and development of an automated screening strategy for at-risk pregnancies
Description: In this study we are identifying early clinical predictors of fetomaternal hemorrhage and piloting multiple laboratory testing strategies to identify the disease in the general pregnant population.
NIH L40 HL090239 7/1/2007-6/30/2009
Epidemiology and management of transient tachypnea of the newborn
Description: In this series of studies, we are investigating the epidemiology and potential novel management strategies for transient tachypnea of the newborn via patient-oriented research and a pilot clinical trial.
Stroustrup A, Bragg JB, Andra SS, Curtin PC, Spear EA, Sison DB, Just AC, Arora M, Gennings C. Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance. PloS one 2018 Mar; 13(3).
Stroustrup A, Teitelbaum SL, Aschner JL. The Value of Preterm Infant Environmental Health Cohorts: The Canary in the Coal Mine. JAMA pediatrics 2017 Oct;.
Stroustrup A, Tetelbaum S, Aschner J. The canary in the coal mine: The value of preterm environmental health cohorts. . JAMA Peds 2017 Oct;: In Press.
Herlihy N, Odom E, Cohen N, Stroustrup A, Rebarber A, Fox NS. Long-Term Outcomes of Small for Gestational Age Twins Born at 34 Weeks or Later. American journal of perinatology 2017 Sep;.
Weintraub AS, Geithner EM, Stroustrup A, Waldman ED. Compassion fatigue, burnout and compassion satisfaction in neonatologists in the US. Journal of Perinatology: Official Journal of the California Perinatal Association 2016 Nov; 36(11).
Stroustrup A, Hsu HH, Svensson K, Schnaas L, Cantoral A, Solano González M, Torres-Calapiz M, Amarasiriwardena C, Bellinger DC, Coull BA, Téllez-Rojo MM, Wright RO, Wright RJ. Toddler temperament and prenatal exposure to lead and maternal depression. Environmental Health: A Global Access Science Source 2016 Jun; 15(1).
Scharf RJ, Stroustrup A, Conaway MR, DeBoer MD. Growth and development in children born very low birthweight. Archives of Disease in Childhood. Fetal and neonatal edition 2016 Sep; 101(5).
Stroustrup A, Plafkin C. A pilot prospective study of fetomaternal hemorrhage identified by anemia in asymptomatic neonates. Journal of Perinatology: Official Journal of the California Perinatal Association 2016 May; 36(5).
Stroustrup A, Plafkin C, Tran TA, Savitz DA. Demographic and Behavioral Predictors of Severe Fetomaternal Hemorrhage: A Case-Control Study. Neonatology 2016 Feb; 109(4).
Scharf RJ, Scharf GJ, Stroustrup A. Developmental Milestones. Pediatrics in Review 2016 Jan; 37(1).
Santos J, Pearce SE, Stroustrup A. Impact of hospital-based environmental exposures on neurodevelopmental outcomes of preterm infants. Current Opinion in Pediatrics 2015 Apr; 27(2).
Webb BD, Scharf RJ, Spear EA, Edelmann LJ, Stroustrup A. Evaluation of the Affymetrix CytoScan(®) Dx Assay for developmental delay. Expert review of molecular diagnostics 2015 Feb; 15(2).
Stroustrup A, Trasande L, Holzman IR. Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn. The Journal of Pediatrics 2012 Jan; 160(1).
Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 2010 Aug; 126(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Stroustrup did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.